The potential mechanism by which CX3CR1 influences CD14+ CD16− monocytes to facilitate the progression of PCa is through activation of the CX3CR1/CX3CL1 signalling pathway, promoting tumour angiogenesis, migration, and invasion.9 Here, CX3CL1 is linked to neoplasm.